Skip to navigation Skip to main content

Elmer News

Elmer Press
Wednesday, February 5, 2025 - 14:47
Elmer Press
Friday, December 20, 2024 - 12:25

Featured Articles

Expression Profile of Thymidine Kinase Genes in Cervical Squamous Cell Carcinoma Confirmed by Various Detection Methods

World Journal of Oncology

Vol. 16, No. 1, Feb 2025, pages 30-50

By Cai Xia Liang et al.

Left Ventricular Non-Compaction, Atrial Fibrillation and ANK2 Mutation in a Young Athlete

Journal of Clinical Medicine Research

Vol. 17, No. 1, Jan 2025, pages 60-65

By Gabriele De Masi De Luca et al.

Role of Serum Biomarkers in the Assessment of Traumatic Brain Injury

Journal of Neurology Research

Vol. 15, No. 1, Jan 2025, pages 12-32

By Michele Chicone et al.

Characterization of Intracardiac Flow in the Right Ventricle With Pressure and Volume Overload in Children

Cardiology Research

Vol. 16, No. 1, Feb 2025 pages 22-32

By Yasunobu Hayabuchi et al.

Prevalence of Self-Reported Halitosis in Individuals With Type 1 and Type 2 Diabetes Mellitus: A Cross-Sectional Study

Journal of Endocrinology & Metabolism

Published Online First

By Mohammed S. Almayouf et al.

An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and Pneumonitis

Journal of Medical Cases

Vol. 16, No. 2, Feb 2025, pages 69-76

By Christodoulos Chatzigrigoriadis et al.

Treatment of Crohn’s Disease With Infliximab and Subsequent Development of Takayasu’s Arteritis

Gastroenterology Research

Vol. 17, No. 5-6, Dec 2024, pages 217-223

By Kei Nomura et al.

Our Mission

Since 2008, ElmerPress strives to provide the international academic community with maximized quality scientific information throughout a wide spectrum of disciplines. ElmerPress understands how hard, and rigorously scientific information is obtained while relentlessly ensuring it is delivered in the quality and urgency it needs and deserves.


Through Peer-Reviewing, Editing, and Publishing, ElmerPress is committed to making sure every scientific discovery is heard with accuracy, presentability, and appropriate credibility. Our Open Access Journals published by ElmerPress are both Peer-Reviewed, and International, dedicated to the rapid academic exchange. The Publisher currently publishes 14 Open Access Medical Journals, focusing on Clinical Medicine Research in various disciplines.

Browse Our Journals                     
The single most important criterion for acceptance is the originality of the work. However, a
The quality of your writing is important to accurately convey your research, we are dedicated to
For submission and publishing inquiries, please reach out to our individual journals

Company Profile

ElmerPress is a medical publishing company based in Toronto, Canada, founded in 2008. With over a decade of experience in the industry, we have established ourselves as a leading provider of high-quality publishing services to clients worldwide. Our team of experienced editors, designers, and project managers work closely with authors, researchers, and publishers to produce medical books, journals, and other publications that are both informative and engaging.


At ElmerPress, we are committed to maintaining the highest standards of quality and professionalism in all our work. We use the latest technology and best practices in the industry to ensure that our clients receive the best possible service and results. Whether you are an author, publisher, or researcher, we are dedicated to helping you achieve your goals and share your work with the world.

Why Choose Us?
Choose ElmerPress for your medical publishing needs to benefit from our decade-long experience in the industry, as well as our commitment to quality and excellence. With a focus on open access and peer-reviewed publications, we offer a range of services to help authors share their research with a global audience.
Seamless Publishing
Our publishing process ensures that you can deliver your research as fast as possible with the quality it deserves.
Our History and Values
Since 2008, ElmerPress has been dedicated to advancing the field of medicine through open access, peer-reviewed publications. We strive to be a reliable partner for authors and readers alike, providing a platform for valuable research to be shared and accessed by a global audience.
Our Committment to Continuous Improvement and Changing Needs
At ElmerPress, we are constantly evolving to meet the changing needs of the medical publishing industry. We invest in cutting-edge technology and stay up-to-date on the latest trends and innovations. Our commitment to continuous improvement allows us to deliver better results and provide an even more seamless experience for our authors and readers

AI Use in Preparing Manuscripts

Use of AI Tools (such as ChatGPT)

1. AI tools (such as ChatGPT) cannot be listed as an author of a paper.
2. If authors use AI tools (such as ChatGPT) in the preparation of a manuscript, they must disclose how the AI tool was used and extent of the usage, in which parts or sections the AI tool was used.
3. Use of AI tools but without disclosure in the manuscript constitutes academic misconduct.
4. Manuscript authors are ultimately responsible for the submitted work.